SOHNGEN MARIOLA,SOHNGEN Mariola,SOHNGEN WOLFGANG,SOHNGEN Wolfgang,SCHLEUNING WOLF-DIETER,SCHLEUNING Wolf-Dieter,MEDCALF ROBERT,MEDCALF Robert
申请号：
SI200432000
公开号：
SI1622639T1
申请日:
2004.04.30
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
The invention relates to the use of non-neurotoxic plasminogen-activating factors, e.g. from Desmodus rotundus (DSPA) or genetically modified plasminogen-activating factors especially of human origin, for producing a therapeutic agent that is to be injected for the therapeutic treatment of stroke in humans.
